FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385055001: Tablet (basic dose form)

  • SNOMED CT Concept\Qualifier value\Basic dose form (basic dose form)\Solid dose form\A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479317011 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3534602016 Tablet (basic dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3635452013 A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
1459233010 Tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479317011 Tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479317011 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2536656014 Tablets en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2536656014 Tablets en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2613089014 Tablet dose form (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2660323018 Tablet dose form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2660323018 Tablet dose form (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2770896013 Tablet dose form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2770896013 Tablet dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3534602016 Tablet (basic dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3635452013 A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
13111000188116 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
13111000188116 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Type of drug preparation false Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Solid dose form true Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Has state of matter (attribute) Solid (state of matter) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely propantheline bromide 15 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely mebeverine hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Mebeverine hydrochloride 135 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Cimetidine 400mg effervescent tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Cimetidine 200 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Cimetidine 400 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cimetidine 800 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release effervescent oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release effervescent oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ranitidine (as ranitidine hydrochloride) 300 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Tripotassium dicitratobismuthate 120 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely sucralfate 1 gram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely famotidine 20 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Famotidine 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely omeprazole 10 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Omeprazole 20 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Omeprazole 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ranitidine bismuth citrate 400 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pantoprazole (as pantoprazole sodium sesquihydrate) 40 milligram/1 each gastro-resistant oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pantoprazole (as pantoprazole sodium sesquihydrate) 20 milligram/1 each gastro-resistant oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely rabeprazole sodium 10 milligram/1 each gastro-resistant oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely rabeprazole sodium 20 milligram/1 each gastro-resistant oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Clarithromycin 500mg tablet and lansoprazole 30mg capsule and amoxycillin 500mg capsule pack Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Esomeprazole 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Esomeprazole 20 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Co-phenotrope 2.5mg/25micrograms tablet (product) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely loperamide hydrochloride 2 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Mesalazine 500mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely mesalazine 400 milligram/1 each gastro-resistant oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely sulfasalazine 500 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Olsalazine sodium 500 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely methylcellulose-450 500 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Senna 7.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ursodeoxycholic acid 300 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Urosodiol 150mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Pancreatin e/c tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Urea[13C] 100mg soluble tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely digoxin 62.5 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Digoxin 125 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Digoxin 250 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Digitoxin 100 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bendroflumethiazide 2.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bendroflumethiazide 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Chlorthalidone 50mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cyclopenthiazide 500 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Indapamide 1.5mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely indapamide 2.5 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Metolazone 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Polythiazide 1 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely xipamide 20 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Furosemide 20 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely furosemide 500 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely bumetanide 1 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bumetanide 5mg tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Torasemide 2.5mg tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Torasemide 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Torasemide 10 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amiloride hydrochloride 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Spironolactone 25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Spironolactone 50 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Spironolactone 100 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Co-triamterzide 50mg/25mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amiloride hydrochloride 5 mg and bumetanide 1 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Co-amilozide 5mg/50mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amiloride hydrochloride 10 milligram and furosemide 80 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bumetanide+potassium 500micrograms/7.7mmol m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Frusemide+potassium 40mg/8Mmol m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Frusemide+potassium 20mg/10mmol m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bendrofluazide+potassium 2.5mg/8.4mmol m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely felodipine 2.5 milligram and ramipril 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Felodipine 5 mg and ramipril 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amiodarone hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amiodarone hydrochloride 200 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Verapamil hydrochloride 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Verapamil hydrochloride 80 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely verapamil hydrochloride 120 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Verapamil hydrochloride 240mg m/r tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Verapamil hydrochloride 120mg m/r tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely verapamil hydrochloride 160 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Disopyramide 150mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Disopyramide 250mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Flecainide acetate 50 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely flecainide acetate 100 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Quinidine sulfate 200 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Propafenone hydrochloride 150 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely propafenone hydrochloride 300 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Moracizine 200 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)

Start Page 2 of 28 Next End

This concept is not in any reference sets

Back to Start